Eye drop showdown: three Anti-Inflammables battle to prevent Post-Surgery swelling
NCT ID NCT07178639
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This trial compares three different NSAID eye drops—bromfenac, nepafenac, and diclofenac—to see which one best prevents macular edema (swelling) after cataract surgery. About 150 adults having cataract surgery will be randomly assigned to one of the three drops. They will be followed for six weeks with eye exams and vision tests to measure outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oblastní nemocnice Kolín a.s.
RECRUITINGKolín, 28002, Czechia
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NSAID eye drops (bromfenac, nepafenac, diclofenac)
What this could lead to
If successful, this study could identify which eye drop is best at preventing swelling after cataract surgery, improving recovery and vision outcomes.
What could go wrong
This is a small, early-stage comparison trial with no placebo group, so results may not apply to all patients. Differences between drugs may be small or not clinically meaningful.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.